ARCHIVES

DCT Advisors Approve Increased Spending On Trials Monitoring

This article is from The Cancer Letter archive.

Vol. 20 No. 18 | May 6, 1994

Download PDF Visit The Full Archive

Related Articles

Tesetaxel Showed 20 Percent Response In Second-Line Therapy In Phase IIb Trial

January 27, 2012

President’s Cancer Panel Special Commission On Breast Cancer Named

April 25, 1992

HEW Finally Moves On Distribution Of Chemicals

September 7, 1979

DCT Board Offers Philosophical, Some Financial Aid to Program Projects, Says They Are “Irreplaceable”

June 18, 1982

Niederhuber Outlines NCI Grant Funding Policies for FY08.

February 8, 2008

Congress Renews National Cancer Act, Including Most Key Amendments Sought By NCI And Allied

October 28, 1988